News & Press Releases

Member Ken Jenkins was quoted in an article by UCSF Innovation Ventures focused on an FDA approved autoimmune drug, Rilzabrutinib, which went from a university invention to a marketable drug.

Siegmund Gutman, Life Science Litigation Practice Chair and Patent Litigation Practice Co-Chair, was quoted by Bloomberg Law in an article focused on the biggest patent lawsuits surrounding pharmaceutical drugs and technologies that are set to go to trial in 2026.

Mintz advised TPG on Cencora’s acquisition of TPG’s equity interest in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology. The transaction follows a period of significant physician-led investment and growth for the platform.